Price Alert: Shares of Magenta (MGTA) Trade 5.00% Higher at Midday June 21

Equities Staff  |

Shares of Magenta Therapeutics Inc (NASDAQ: MGTA) are up 5.00% Tuesday.

As of 11:59:38 est, Magenta is currently sitting at $1.16 and has climbed $0.055 so far today.

Magenta has moved 9.84% over the last 30 days and has moved YTD 75.17% based on the prior day’s close.

The company is set to release earnings on 2022-08-04.

For technical charts, analysis, and more on Magenta visit the company profile.

About Magenta Therapeutics Inc

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

To get more information on Magenta Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Magenta Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content